Korro Bio, Inc. 8-K

What Happened

• On March 12, 2026, Korro Bio, Inc. (KRRO) announced its financial results for the year ended December 31, 2025 via a press release.
• The company furnished the full text of that press release as Exhibit 99.1 to a Form 8-K under Item 2.02 (Results of Operations and Financial Condition); the press release is incorporated by reference into the filing.

Key Details

• Filing date: March 12, 2026.
• Reporting period: Year ended December 31, 2025.
• Exhibit furnished: Exhibit 99.1 — press release with the financial results; Exhibit 104 — Inline XBRL cover page data file embedded.
• Item in Form 8-K: 2.02 (Results of Operations and Financial Condition); exhibits listed under Item 9.01.

Why It Matters

• This 8-K is the company’s formal notice that updated annual financial results have been released; investors should review the attached press release (Exhibit 99.1) for details on revenue, expenses, net income/loss, cash position, and any commentary from management.
• Because the filing signals new financial information for the 2025 year, it may be material to valuation and near-term trading; retail investors should read the press release and monitor upcoming periodic filings (e.g., Form 10-K) for audited and more detailed financial statements.